当前位置: X-MOL 学术Acta Biochim. Biophys. Sin. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
LncRNA OIP5-AS1 facilitates gastric cancer cell growth by targeting the miR-422a/ANO1 axis.
Acta Biochimica et Biophysica Sinica ( IF 3.3 ) Pub Date : 2020-04-20 , DOI: 10.1093/abbs/gmaa012
Rongjun Xie 1 , Longfei Liu 1 , Xianzhou Lu 1 , Yang Hu 1
Affiliation  

OPA-interacting protein 5 antisense transcript 1 (OIP5-AS1) plays an important regulatory role in various types of cancers. However, the functional role and regulatory mechanisms of OIP5-AS1 in gastric cancer (GC) remain largely unknown. In this study, we found that the expression of OIP5-AS1 was increased in GC tissues compared with that in adjacent non-cancerous tissues, which was significantly associated with shorter overall survival time of patients. In addition, OIP5-AS1 expression was also increased in GC cell lines including NCI-N87, MKN-45, BGC-823 and SGC-7901, when compared with that in normal gastric epithelial cell line GES-1. Knockdown of OIP5-AS1 markedly suppressed the proliferation and colony formation activities of GC cells, induced G0/G1 arrest and apoptosis of GC cells in vitro, and restrained tumor growth in vivo. Mechanistically, OIP5-AS1 functions as an oncogenic competing endogenous RNA by binding to and sequestering miR-422a to elevate the expression of anoctamin-1. Our study first demonstrated that OIP5-AS1 is a critical and powerful regulator of GC pathogenesis and may represent a novel candidate target for GC therapy.

中文翻译:

LncRNA OIP5-AS1通过靶向miR-422a / ANO1轴促进胃癌细胞的生长。

与OPA相互作用的蛋白5反义转录本1(OIP5-AS1)在各种类型的癌症中起着重要的调节作用。但是,OIP5-AS1在胃癌(GC)中的功能作用和调节机制仍然未知。在这项研究中,我们发现与相邻的非癌性组织相比,GC组织中OIP5-AS1的表达增加,这与患者总体生存时间的缩短显着相关。另外,与在正常胃上皮细胞系GES-1中相比,在包括NCI-N87,MKN-45,BGC-823和SGC-7901的GC细胞系中,OIP5-AS1的表达也增加了。抑制OIP5-AS1可以显着抑制GC细胞的增殖和集落形成活性,在体外诱导GC细胞的G0 / G1阻滞和凋亡,并在体内抑制肿瘤的生长。从机理上讲,OIP5-AS1通过与miR-422a结合并螯合miR-422a以提高anoctamin-1的表达而起竞争性内源性RNA的作用。我们的研究首次证明,OIP5-AS1是GC发病机制的关键且功能强大的调节剂,可能代表了GC治疗的新候选靶点。
更新日期:2020-04-20
down
wechat
bug